A recent report published by
Infinium Global Research on the parenteral nutrition market provides an
in-depth analysis of segments and sub-segments in the global as well as
regional parenteral nutrition market. The study also highlights the impact of
drivers, restraints, and macro indicators on the global and regional parenteral
nutrition market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecasts, and dollar values of the
global parenteral nutrition market. According to the report, the global market for parenteral nutrition was sized USD 5.7 billion in 2020 and
is expected to reach over USD 8.1 billion by 2026 growing with a CAGR of 5.8%
Parenteral nutrition refers to the
intravenous administration of nutrient solutions to patients. It is a process
by which liquid nutrients are inoculated into the body through the veins.
Parenteral nutrition is generally used in a medical condition where a patient
is not able to get sufficient nutrients through the food owing to the
obstruction of the gastrointestinal tract. This leads to inadequate nourishment
of the body. Furthermore, parenteral nutrition is typically designed for people
suffering from Crohn’s disease, short bowel syndrome, and cancer. It aids to
prevent malnutrition in patients who are unable to obtain adequate nutrients by
oral or enteral routes. Nowadays, numerous commercial treatments and therapy
are available in the markets which are used for different medical conditions.
These commercially available premixed solutions efficiently provide nutrition
for short periods, nevertheless in complex patients, personalizing parenteral
nutrition is preferred.
An increase in the incidence of
diseases that require parenteral nutrition such as gastrointestinal disorders,
malnutrition, cancer, acquired immunodeficiency syndrome, etc. is the primary
reason for the high growth of the parenteral nutrition market. Furthermore, the rise in the elderly population is another reason for market growth as this group is more prone to chronic diseases and needs more parenteral nutrition
support in comparison to the young population. On the other hand, the shortage
of skilled healthcare professionals and the risk of health complications owing
to poor monitoring are hindering the growth of the parenteral nutrition market.
However, rising technological innovation in parenteral therapy and growing
demand for parenteral nutrition services around the globe with a significant rise in parenteral nutrition awareness is anticipated to offer lucrative
opportunities for key players in the projection period.
Among the geographies, the North
America region is expected to hold the largest share in the global parenteral
nutrition market. The growth is owing to the presence of technologically
advanced medical facilities, an increase in healthcare expenditure, and a
growing geriatric population is anticipated to keep this region in the leading
position during the prediction period. However, the Asia Pacific region is
expected to witness the fastest growth in the parenteral nutrition market
during the forecast period. Emerging economies such as India and China are
accelerating the growth of this region due to favorable government initiatives
towards the development of healthcare infrastructure and increased corporate
investments in the healthcare sector are projected to augment the growth of the
parenteral nutrition market over the forecast period.
The report on the global parenteral
nutrition market covers segments such as nutrient type, dosage form, and
end-user. On the basis of nutrient type, the sub-markets include carbohydrates,
amino acids, lipids, electrolytes, and others (multivitamin formulations and
trace elements). On the basis of dosage form, the sub-markets include bags,
vials, ampules, and bottles. On the basis of end-user, the sub-markets include
clinics, hospitals, and others.
The report provides profiles of
the companies in the market such as B. Braun Melsungen AG, Fresenius Kabi AG,
Allergan Plc, Grifols, S.A., Pfizer, Inc. (Hospira), Otsuka Pharmaceutical
Factory, Inc., Baxter International, Inc., Sichuan Kelun Pharmaceutical Co.,
Ltd, Vifor Pharma, and Aculife (Nirlife).
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of the parenteral nutrition market. Moreover, the study highlights current
market trends and provides forecast from 2020-2026. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players.